Cargando…

Differential Analysis of Ovarian and Endometrial Cancers Identifies a Methylator Phenotype

Despite improved outcomes in the past 30 years, less than half of all women diagnosed with epithelial ovarian cancer live five years beyond their diagnosis. Although typically treated as a single disease, epithelial ovarian cancer includes several distinct histological subtypes, such as papillary se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kolbe, Diana L., DeLoia, Julie A., Porter-Gill, Patricia, Strange, Mary, Petrykowska, Hanna M., Guirguis, Alfred, Krivak, Thomas C., Brody, Lawrence C., Elnitski, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293923/ https://www.ncbi.nlm.nih.gov/pubmed/22403726 http://dx.doi.org/10.1371/journal.pone.0032941

Ejemplares similares

Differential gene expression identifies a transcriptional regulatory network involving ER-alpha and PITX1 in invasive epithelial ovarian cancer
por: Li, Yichao, et al.
Publicado: (2021)

Assessing ZNF154 methylation in patient plasma as a multicancer marker in liquid biopsies from colon, liver, ovarian and pancreatic cancer patients
por: Miller, Brendan F., et al.
Publicado: (2021)

Assessment of the Prognostic Value of Two Common Variants of BRCA1 and BRCA2 Genes in Ovarian Cancer Patients Treated with Cisplatin and Paclitaxel: A Gynecologic Oncology Group Study
por: Tian, Chunqiao Q., et al.
Publicado: (2013)

BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study
por: Lesnock, J L, et al.
Publicado: (2013)

Bidirectional Promoters as Important Drivers for the Emergence of Species-Specific Transcripts
por: Gotea, Valer, et al.
Publicado: (2013)

MethylToSNP: identifying SNPs in Illumina DNA methylation array data
por: LaBarre, Brenna A., et al.
Publicado: (2019)

Coordinate up-regulation of TMEM97 and cholesterol biosynthesis genes in normal ovarian surface epithelial cells treated with progesterone: implications for pathogenesis of ovarian cancer
por: Wilcox, Cathy B, et al.
Publicado: (2007)

Identification of human silencers by correlating cross-tissue epigenetic profiles and gene expression
por: Huang, Di, et al.
Publicado: (2019)

DNA methylation profiles unique to Kalahari KhoeSan individuals
por: Goncearenco, Alexander, et al.
Publicado: (2020)

Leveraging locus-specific epigenetic heterogeneity to improve the performance of blood-based DNA methylation biomarkers
por: Miller, Brendan F., et al.
Publicado: (2020)

Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer
por: Abkevich, V, et al.
Publicado: (2012)

Evaluating Stacked Methylation Markers for Blood-Based Multicancer Detection
por: Funderburk, Karen, et al.
Publicado: (2023)

CpG island methylator phenotype in adenocarcinomas from the digestive tract: Methods, conclusions, and controversies
por: Sánchez-Vega, Francisco, et al.
Publicado: (2017)

Invasive endometrial adenocarcinoma and missed abortion: A case report
por: Gaulin, Nicole B., et al.
Publicado: (2019)

Pan-cancer stratification of solid human epithelial tumors and cancer cell lines reveals commonalities and tissue-specific features of the CpG island methylator phenotype
por: Sánchez-Vega, Francisco, et al.
Publicado: (2015)

Proteomic Analysis of Matched Formalin-Fixed, Paraffin-Embedded Specimens in Patients with Advanced Serous Ovarian Carcinoma
por: Smith, Ashlee L., et al.
Publicado: (2013)

Aberrant DNA methylation defines isoform usage in cancer, with functional implications
por: Chen, Yun-Ching, et al.
Publicado: (2019)

PARP Inhibitors in Ovarian Cancer: A Review
por: O’Malley, David M., et al.
Publicado: (2023)

Unique Alterations of an Ultraconserved Non-Coding Element in the 3′UTR of ZIC2 in Holoprosencephaly
por: Roessler, Erich, et al.
Publicado: (2012)

The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings
por: Chang, Cheng-Chang, et al.
Publicado: (2018)

A Systems Biology Comparison of Ovarian Cancers Implicates Putative Somatic Driver Mutations through Protein-Protein Interaction Models
por: Yang, Mary Qu, et al.
Publicado: (2016)

Preoperative high dose rate brachytherapy for clinical stage II endometrial carcinoma
por: Shukla, Gaurav, et al.
Publicado: (2011)

Synchronous endometrial and ovarian cancer: A case report
por: Žilovič, Diana, et al.
Publicado: (2023)

A Delay from Diagnosis to Treatment Is Associated with a Decreased Overall Survival for Patients with Endometrial Cancer
por: Dolly, Darren, et al.
Publicado: (2016)

Genome-wide detection of a TFIID localization element from an initial human disease mutation
por: Yang, Mary Q., et al.
Publicado: (2011)

Gene Promoter Methylation in Endometrial Carcinogenesis
por: Cornel, Karlijn M. C., et al.
Publicado: (2018)

Comprehensive Annotation of Bidirectional Promoters Identifies Co-Regulation among Breast and Ovarian Cancer Genes
por: Yang, Mary Q, et al.
Publicado: (2007)

High DNA methylation age deceleration defines an aggressive phenotype with immunoexclusion environments in endometrial carcinoma
por: Hao, Jing, et al.
Publicado: (2023)

Significant associations between driver gene mutations and DNA methylation alterations across many cancer types
por: Chen, Yun-Ching, et al.
Publicado: (2017)

Proteomic Analysis of Ovarian Cancer Proximal Fluids: Validation of Elevated Peroxiredoxin 1 in Patient Peripheral Circulation
por: Hoskins, Ebony R., et al.
Publicado: (2011)

Phenotype of POLE-mutated endometrial cancer
por: Imboden, Sara, et al.
Publicado: (2019)

Evaluation of a chemoresponse assay as a predictive marker in the treatment of recurrent ovarian cancer: further analysis of a prospective study
por: Tian, C, et al.
Publicado: (2014)

Ovarian Metastasis in Endometriod Type Endometrial Cancer
por: Gilani Modaress, Mitra, et al.
Publicado: (2011)

Chemoresistance and targeted therapies in ovarian and endometrial cancers
por: Brasseur, Kevin, et al.
Publicado: (2016)

Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome
por: Reijnen, Casper, et al.
Publicado: (2020)

Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era
por: Berger, Jessica L, et al.
Publicado: (2014)

Research Progress of DNA Methylation in Endometrial Cancer
por: Xu, Ting, et al.
Publicado: (2022)

Synchronous Endometrial and Ovarian Carcinoma: A Case Series
por: Makris, Georgios-Marios, et al.
Publicado: (2017)

Trends and outcomes of women with synchronous endometrial and ovarian cancer
por: Matsuo, Koji, et al.
Publicado: (2018)

Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma
por: Yoneoka, Yutaka, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_je0c00ijns4moiqvtnbkugn82d